Document Detail

A review of UVB-mediated photosensitivity disorders.
MedLine Citation:
PMID:  23023766     Owner:  NLM     Status:  Publisher    
Photosensitivity to UVB is a prominent feature of a small number of congenital skin disorders. In addition UVB may also contribute to the action spectrum of a number of acquired photosensitivity syndromes. The gene mutations underlying the genetically inherited disorders have largely been identified and have provided insights into DNA repair pathways. The pathomechanisms for the acquired disorders are still largely undefined. Few therapeutic options are available so management of all these disorders still relies on rigorous photo-protection.
F Kiss; A V Anstey
Related Documents :
23395036 - The management of acetabular retroversion with reverse periacetabular osteotomy.
21405316 - Localized and extended states in a disordered trap.
23338216 - Postpartum psychiatric disorders : guidelines for management.
24701616 - Paediatric psychological problems.
11110016 - Selective serotonin reuptake inhibitors in the treatment of panic disorder and agorapho...
9525246 - Transient vocal fold immobility.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-10-1
Journal Detail:
Title:  Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology     Volume:  -     ISSN:  1474-9092     ISO Abbreviation:  Photochem. Photobiol. Sci.     Publication Date:  2012 Oct 
Date Detail:
Created Date:  2012-10-1     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101124451     Medline TA:  Photochem Photobiol Sci     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Aneurin Bevan Health Board, St Woolos Hospital, Stow Hill, Newport, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Impact of Protease Inhibitors on Dentin Matrix Degradation by Collagenase.
Next Document:  On the choice of doses for phase III clinical trials.